Page 3 - Head External News Today

Investegate announcements from Santhera Pharmaceuticals Holdi, Santhera Announces First Half-Year 2021 Financial Results and Updates on Corporate Progress

Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, October 1, 2021: SIX Exchange Regulation has permitted Santhera to publish its interim report for the six-month period ended June 30

Webrepublic unterstützt den Schweizer Finanzdienstleister SIX neuerdings in der digitalen Kommunikation. Dafür wurde nun eine erste «holistische Strategie» ausgearbeitet, wie dem Klein Report am Mittwoch mitgeteilt wurde. Diese beinhaltet eine «Schärfung der digitalen Kommunikations-Vision des Unternehmens sowie eine Kampagnenkonzeption». Zudem werde die Zürcher Agentur Webrepublic das digitale Wissen der Mitarbeitenden von SIX «fortlaufend erweitern». Konkret wird die Partnerschaft ve...

Trao tặng phí phẫu thuật thay máy tạo nhịp tim cho trẻ em khó khăn K. M - 08:37 06/07/2021 GMT+7 Suckhoedoisong.vn - Hội Chữ thập đỏ Việt Nam cho biết, ngày 5/7, Quỹ hoạt động Chữ thập đỏ vừa tổ chức trao tặng phí phẫu thuật thay máy tạo nhịp tim cho trẻ em có hoàn cảnh khó khăn đang...

Santhera Pharmaceuticals Holding AG: Santhera Publishes Agenda for its Annual General Meeting the invitation to its Annual General Meeting (AGM) , at 10:30 . Invitation and agenda items for the AGM The invitation and agenda items for the Annual General Meeting can be viewed on Santheras website at https://www.santhera.com/investors-and-media/investor-toolbox/share-bondholder-meetings. Selected agenda items: increases As previously announced, the Board of Directors (BoD) proposes various ca...

is starting today on the SIX Swiss Exchange. On May 4, 2021, Santhera Pharmaceuticals Holding AG issued Senior Unsecured Convertible Bonds due 2024 (the 2021/24 Bonds) in the aggregate principal amount of CHF 30,270,375. The 2021/24 Bonds have been admitted to trading on the SIX Swiss Exchange. The first trading day is today, May 7, 2021. The ticker symbol of the 2021/24 Bonds is SAN21 and ISIN CH0563348744. As set out in the terms and conditions [1], the conversion period during which a ...

Santhera Pharmaceuticals Holding AG: Santhera gibt den ersten Handelstag der neuen Wandelanleihe an der SIX Swiss Exchange bekannt Pratteln, Schweiz, vorrangigen 375 mit Fälligkeit 2024 heute an der SIX Swiss Exchange beginnt. Am 4. Mai 2021 hat die Santhera Pharmaceuticals Holding AG eine vorrangige ungesicherte Wandelanleihe mit Fälligkeit 2024 (die Anleihe 2021/24) im Gesamtnennbetrag von CHF 30270 375 ausgegeben. Die Anleihe 2021/24 wurde zum Handel an der SIX Swiss Exchange zugelassen...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO Pratteln, Switzerland, May 4, 2021 – Santhera ...

Santhera Pharmaceuticals Holding AG: Santhera Announces Settlement of Exchange Offer and Issuance of New Senior Unsecured Convertible Bonds due 2024 Pratteln, Switzerland, s the settlement of the e . Santhera Pharmaceuticals Holding AG is settling today its offer to exchange its outstanding CHF 60 million 5% Convertible Bonds due 2022 (the 2017/22 Bonds) on the terms set out in the Notice of Repurchase Offer dated March 25, 2021 (the Exchange Offer). Upon settlement, 2017/22 Bonds in the a...

By Notice of Repurchase Offer dated March 25, 2021 (the Notice), Santhera Pharmaceuticals Holding AG announced an offer to exchange its outstanding CHF 60 million 5% Convertible Bonds due 2022 (the 2017/22 Bonds) on the terms set out in the Notice (the Exchange Offer). The Exchange Offer was accepted by bondholders with respect to 2017/22 Bonds with an aggregate principal amount of CHF 44,845,000, corresponding to 74.7% of all 2017/22 Bonds in circulation. S ettlement Santhera has decide...